Harvard Management as of Sept. 30, 2021
Portfolio Holdings for Harvard Management
Harvard Management holds 40 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apple (AAPL) | 15.6 | $267M | 1.9M | 141.50 | |
| Royalty Pharma Shs Class A (RPRX) | 15.1 | $258M | 7.1M | 36.14 | |
| Facebook Cl A (META) | 14.2 | $242M | 713k | 339.39 | |
| Scientific Games (LNW) | 13.0 | $223M | 2.7M | 83.07 | |
| Alphabet Cap Stk Cl A (GOOGL) | 9.6 | $163M | 61k | 2673.52 | |
| Affirm Hldgs Com Cl A (AFRM) | 5.3 | $90M | 754k | 119.13 | |
| Abcellera Biologics (ABCL) | 4.8 | $82M | 4.1M | 20.04 | |
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 2.1 | $36M | 101k | 357.96 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.0 | $35M | 1.5M | 23.01 | |
| Ishares Tr Core S&p500 Etf (IVV) | 1.6 | $28M | 65k | 430.83 | |
| 10x Genomics Cl A Com (TXG) | 1.6 | $27M | 186k | 145.58 | |
| Sana Biotechnology (SANA) | 1.5 | $26M | 1.2M | 22.52 | |
| Revolution Medicines (RVMD) | 1.1 | $18M | 670k | 27.51 | |
| Relay Therapeutics (RLAY) | 1.0 | $17M | 541k | 31.53 | |
| Rocket Lab Usa | 0.9 | $16M | 1.0M | 16.13 | |
| Spdr Gold Tr Gold Shs (GLD) | 0.9 | $15M | 92k | 164.22 | |
| Praxis Precision Medicines I | 0.8 | $14M | 779k | 18.49 | |
| Purecycle Technologies (PCT) | 0.8 | $14M | 1.1M | 13.28 | |
| Tenaya Therapeutics (TNYA) | 0.8 | $14M | 673k | 20.65 | |
| Generation Bio | 0.7 | $13M | 510k | 25.07 | |
| Fulcrum Therapeutics (FULC) | 0.7 | $12M | 411k | 28.21 | |
| Kinnate Biopharma | 0.7 | $12M | 498k | 23.02 | |
| Meli Kaszek Pioneer Corp Class A Ord | 0.6 | $11M | 1.0M | 11.05 | |
| Pliant Therapeutics (PLRX) | 0.6 | $9.5M | 562k | 16.88 | |
| Nurix Therapeutics (NRIX) | 0.6 | $9.4M | 315k | 29.96 | |
| Tango Therapeutics (TNGX) | 0.5 | $9.2M | 708k | 12.93 | |
| Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA) | 0.5 | $8.2M | 163k | 50.49 | |
| Pacific Biosciences of California (PACB) | 0.3 | $5.9M | 229k | 25.55 | |
| Surrozen | 0.3 | $5.9M | 827k | 7.08 | |
| Ishares Tr Core S&p Scp Etf (IJR) | 0.3 | $5.4M | 50k | 109.18 | |
| Fs Development Corp Ii Com Cl A | 0.2 | $4.0M | 400k | 9.95 | |
| Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 0.2 | $3.7M | 74k | 50.01 | |
| Ishares Tr Core S&p Mcp Etf (IJH) | 0.2 | $3.3M | 13k | 263.11 | |
| Decibel Therapeutics | 0.1 | $2.5M | 329k | 7.71 | |
| Magenta Therapeutics | 0.1 | $2.4M | 333k | 7.28 | |
| Dyne Therapeutics (DYN) | 0.1 | $1.7M | 107k | 16.24 | |
| Gemini Therapeutics | 0.1 | $1.0M | 250k | 4.04 | |
| Seres Therapeutics | 0.1 | $918k | 132k | 6.96 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $124k | 108k | 1.14 | |
| Amplitude Cl A Ord Class A Ord (AMPL) | 0.0 | $29k | 540.00 | 53.70 |
